Treatment of inflammatory pain with IL-20 antagonists

摘要

Using an IL-20 antagonist to reduce inflammatory pain in a subject who has or is suspected of having inflammatory pain; an IL-20 antagonist may induce a signaling pathway mediated by IL-20 It may be an antibody that blocks. Such antibodies include anti-IL-20 antibodies and anti-IL-20R antibodies that specifically block the IL-20 signaling pathway.